NCT04089189 2026-01-28
SABRINA
Impact Therapeutics, Inc.
Phase 2 Completed
Clinical Trials
3 trialsNCT06617923 2025-10-27
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Recruiting
NCT03508011 2021-03-30
A Study of IMP4297 in Patients With Advanced Solid Tumors
Impact Therapeutics, Inc.
Phase 1 Completed